empacyrl25&5mg30tab

Empacyrl is a combination medication used in the management of type 2 diabetes mellitus. It contains Empagliflozin and Linagliptin, which work together to improve glycemic control in adults. Empagliflozin is an SGLT2 inhibitor that helps the kidneys remove glucose from the bloodstream through urine, while Linagliptin is a DPP-4 inhibitor that increases the levels of incretin hormones to stimulate insulin release and decrease glucagon levels. This dual-action approach helps maintain stable blood sugar levels when diet and exercise alone are insufficient.